Literature DB >> 16860030

Anemia, renal dysfunction, and their interaction in patients with chronic heart failure.

Ramesh de Silva1, Alan S Rigby, Klaus K A Witte, Nikolay P Nikitin, Lwin Tin, Kevin Goode, Sunil Bhandari, Andrew L Clark, John G F Cleland.   

Abstract

Anemia and renal dysfunction (RD) are frequent complications seen in chronic heart failure (HF). However, the prevalence and interaction of these co-morbidities in a representative population of outpatients with chronic HF is poorly described. In this study, it was sought to determine the association between RD and anemia in patients with HF enrolled in a community-based HF program. Nine hundred fifty-five patients with HF due to left ventricular systolic dysfunction were investigated for the prevalence of anemia and its cause and followed for a median of 531 days. Anemia was defined as hemoglobin < 12.0 g/dl in women and < 13.0 g/dl in men. RD was defined as a calculated glomerular filtration rate of < 60 ml/min. The prevalence of anemia was 32%. Fifty-three percent of patients with and 27% of those without anemia had > or = 1 test suggesting hematinic deficiency. The prevalence of RD was 54%. Forty-one percent of patients with and 22% of patients without RD had anemia, with similar proportions associated with iron deficiency in the presence or absence of RD. Anemia and RD independently predicted a worse outcome, and this effect was additive. In conclusion, in outpatients with chronic HF, anemia and RD are common and co-exist but confer independent prognostic information. A deficiency of conventional hematinic factors may cause about 1/3 of anemia in this clinical setting.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16860030     DOI: 10.1016/j.amjcard.2006.01.107

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  33 in total

1.  Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms.

Authors:  Chiara Barisione; Silvano Garibaldi; Claudio Brunelli; Manrico Balbi; Paolo Spallarossa; Marco Canepa; Pietro Ameri; Francesca Viazzi; Daniela Verzola; Alessandra Lorenzoni; Riccardo Baldassini; Domenico Palombo; Bianca Pane; Giovanni Spinella; Giorgio Ghigliotti
Journal:  Intern Emerg Med       Date:  2015-10-28       Impact factor: 3.397

Review 2.  Intravenous iron in heart failure: beyond targeting anemia.

Authors:  Donald S Silverberg; Adrian Iaina; Doron Schwartz; Dov Wexler
Journal:  Curr Heart Fail Rep       Date:  2011-03

Review 3.  Iron in kidney and heart failure: from theory to practice.

Authors:  Aslihan Yerlikaya; Mustafa C Bulbul; Baris Afsar; Tuncay Dagel; Gamze Aslan; Luminita Voroneanu; Dimitire Siriopol; Adrian Covic; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2017-09-22       Impact factor: 2.370

4.  Fluid Management in Patients with Chronic Heart Failure.

Authors:  Pierpaolo Pellicori; Kuldeep Kaur; Andrew L Clark
Journal:  Card Fail Rev       Date:  2015-10

Review 5.  Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches.

Authors:  Dirk J van Veldhuisen; Stefan D Anker; Piotr Ponikowski; Iain C Macdougall
Journal:  Nat Rev Cardiol       Date:  2011-05-31       Impact factor: 32.419

Review 6.  Heart failure and anemia: mechanisms and pathophysiology.

Authors:  Inder S Anand
Journal:  Heart Fail Rev       Date:  2008-01-31       Impact factor: 4.214

Review 7.  Iron and anemia in human biology: a review of mechanisms.

Authors:  Garry J Handelman; Nathan W Levin
Journal:  Heart Fail Rev       Date:  2008-03-25       Impact factor: 4.214

Review 8.  Iron deficiency anemia in heart failure.

Authors:  Natasha P Arora; Jalal K Ghali
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

Review 9.  The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes.

Authors:  Yi-Da Tang; Stuart D Katz
Journal:  Heart Fail Rev       Date:  2008-02-02       Impact factor: 4.214

10.  Relationship between blood pressure levels and adherence to medication in patients with chronic heart failure: how come?

Authors:  Mahsa Mohammadi; Inger Ekman; Maria Schaufelberger
Journal:  Vasc Health Risk Manag       Date:  2009-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.